Somatostatin Analogs Market Report By Indication (Acromegaly, Neuroendocrine Tumors (NETs), Cushing's Syndrome, Carcinoid Syndrome, Gastrointestinal Disorders, Others), By Type of Analog (Octreotide (Sandostatin), Lanreotide (Somatuline), Pasireotide (Signifor), Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Others), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
